Atul Gawande

Articles

People who shaped healthcare in 2014 (Part 3)

In the third part of our review of 2014, Andrew McConaghie looks at five more individuals who played a prominent role in shaping healthcare this year.

News

Intellia’s president and chief executive John Leonard

Intellia files CRISPR drug after historic phase 3 readout

Intellia has reported the first-ever phase 3 results with an in vivo gene-editing therapy, CRISPR-based lonvo-z for hereditary angioedema.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks